YaoGeJu

Company directoryChina company filings

Hunan Sailong Pharmaceutical Co.,Ltd

As of 18 November 2026, for the company name Hunan Sailong Pharmaceutical Co.,Ltd as recorded, the chemical-drug catalogue lists 17 active records with this name as holder; 32 active API registrations list this name as first registered company.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/18
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.

Drug filings

20 acceptance records as first applicant, grouped into 12 source drug names. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Tranexamic Acid Injection 4 records · Latest accepted 2026/09/23

Supplement · 4

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2601801Supplement2026/09/23Hunan Sailong Pharmaceutical Co.,Ltd; Hunan Sai Long Pharma (Changsha) Co., Ltd. romanizedCDE ↗
CYHB2201800Supplement2022/09/30Hunan Sailong Pharmaceutical Co.,Ltd; Hunan Sai Long Pharma (Changsha) Co., Ltd. romanizedCDE ↗
CYHB2150700Supplement2021/07/05Hunan Sailong Pharmaceutical Co.,LtdCDE ↗
CYHB2150179Supplement2021/03/27Hunan Sailong Pharmaceutical Co.,LtdCDE ↗
Argatroban Injection 2 records · Latest accepted 2026/07/20

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2601376Supplement2026/07/20Hunan Sailong Pharmaceutical Co.,Ltd; Hunan Sai Long Pharma (Changsha) Co., Ltd. romanizedCDE ↗
CYHB2150718Supplement2021/07/08Hunan Sailong Pharmaceutical Co.,LtdCDE ↗
注射用右兰索拉唑 · No verified English name 2 records · Latest accepted 2025/04/08

Generic · 1Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2501333Generic2025/04/08Hunan Sailong Pharmaceutical Co.,LtdCDE ↗
CXHB2200167Supplement2022/10/10Hunan Sailong Pharmaceutical Co.,LtdCDE ↗
Tedizolid Phosphate For Injection 1 records · Latest accepted 2024/11/26

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2404060Generic2024/11/26Hunan Sailong Pharmaceutical Co.,LtdCDE ↗
Pregabalin Capsules 2 records · Latest accepted 2024/03/20

Supplement · 1Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2400404Supplement2024/03/20Hunan Sailong Pharmaceutical Co.,Ltd; Hunan Sai Long Pharma (Changsha) Co., Ltd. romanizedCDE ↗
CYHS2200350Generic2022/02/21Hunan Sailong Pharmaceutical Co.,Ltd; Hunan Sai Long Pharma (Changsha) Co., Ltd. romanizedCDE ↗
Fosaprepitant Dimeglumine for Injection 2 records · Latest accepted 2023/12/22

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHL2300156Generic2023/12/22Hunan Sailong Pharmaceutical Co.,LtdCDE ↗
CYHS2101342Generic2021/06/28Hunan Sailong Pharmaceutical Co.,LtdCDE ↗
Esomeprazole Sodium for Injection 2 records · Latest accepted 2022/09/10

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2201631Supplement2022/09/10Hunan Sailong Pharmaceutical Co.,Ltd; Hunan Sai Long Pharma (Changsha) Co., Ltd. romanizedCDE ↗
CYHB2200053Supplement2022/01/11Hunan Sailong Pharmaceutical Co.,Ltd; Hunan Sai Long Pharma (Changsha) Co., Ltd. romanizedCDE ↗
Apixaban Tablets 1 records · Latest accepted 2022/03/22

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2200472Generic2022/03/22Hunan Sailong Pharmaceutical Co.,Ltd; Hunan Sai Long Pharma (Changsha) Co., Ltd. romanizedCDE ↗
Tigecycline for Injection 1 records · Latest accepted 2021/06/25

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2150697Supplement2021/06/25Hunan Sailong Pharmaceutical Co.,LtdCDE ↗
Thymalfasin for Injection 1 records · Latest accepted 2021/03/25

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2150173Supplement2021/03/25Hunan Sailong Pharmaceutical Co.,LtdCDE ↗
门冬氨酸鸟氨酸注射液 · No verified English name 1 records · Latest accepted 2021/01/11

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2100070Supplement2021/01/11Hunan Sailong Pharmaceutical Co.,LtdCDE ↗
注射用左旋泮托拉唑钠 · No verified English name 1 records · Latest accepted 2020/01/08

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS1900885Generic2020/01/08Hunan Sailong Pharmaceutical Co.,LtdCDE ↗

Changes in the last 90 days

3 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Accepted: 1 applicationNo longer listed under review: 1 applicationNotification delivery: 1 application

  1. 2026/11/18No longer listed under review

    Argatroban Injection

    CYHB2601376

    Fact date: 2026/11/18 · Date added to this site: 2026/11/18

    Accepted: 2026/07/20

    no longer on the CDE under-review list as of the data cut-off; NMPA published notification delivery for this acceptance number on 2026/11/17; the notification contents are not public and the outcome remains unverified; this is a supplemental application, not counted as a new marketing approval · NMPA source · row 7

    NMPA · Table row 7 ↗ View source ↗
  2. 2026/11/17Notification delivery

    Argatroban Injection

    CYHB2601376

    Fact date: 2026/11/17 (Publication date) · Publication date: 2026/11/17 · Date added to this site: 2026/11/17

    Notification delivered; the specific outcome remains to be checked.

    View source · Table row 7 ↗
  3. 2026/09/23Accepted

    Tranexamic Acid Injection

    CYHB2601801

    Fact date: 2026/09/23 · Date added to this site: 2026/10/22

    View source ↗

Under review

2 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Tranexamic Acid Injection CYHB2601801Supplement2026/09/23Hunan Sailong Pharmaceutical Co.,Ltd; Hunan Sai Long Pharma (Changsha) Co., Ltd. romanizedCDE ↗
注射用左旋泮托拉唑钠 · No verified English name CYHS1900885Generic2020/01/08Hunan Sailong Pharmaceutical Co.,LtdCDE ↗

Catalogue holder records

17 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
注射用右兰索拉唑 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdHunan Sailong Pharmaceutical Co.,Ltd国药准字H202653722026/07/28Generic approved under the new chemical-drug registration classificationCDE ↗
Tedizolid Phosphate For InjectionHunan Sailong Pharmaceutical Co.,LtdHunan Sailong Pharmaceutical Co.,Ltd国药准字H202643932026/05/19Generic approved under the new chemical-drug registration classificationCDE ↗
Pregabalin CapsulesHunan Sailong Pharmaceutical Co.,LtdHunan Sai Long Pharma (Changsha) Co., Ltd. romanized国药准字H202472802024/11/07Generic approved under the new chemical-drug registration classificationCDE ↗
Pregabalin CapsulesHunan Sailong Pharmaceutical Co.,LtdHunan Sai Long Pharma (Changsha) Co., Ltd. romanized国药准字H202432612024/02/23Generic approved under the new chemical-drug registration classificationCDE ↗
Apixaban TabletsHunan Sailong Pharmaceutical Co.,LtdHunan Sai Long Pharma (Changsha) Co., Ltd. romanized国药准字H202346042023/12/05Generic approved under the new chemical-drug registration classificationCDE ↗
Argatroban InjectionHunan Sailong Pharmaceutical Co.,LtdHunan Sailong Pharmaceutical Co.,Ltd国药准字H202270902022/07/07Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Thymalfasin for InjectionHunan Sailong Pharmaceutical Co.,LtdHunan Sailong Pharmaceutical Co.,Ltd国药准字H201933852022/04/08Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Tigecycline for InjectionHunan Sailong Pharmaceutical Co.,LtdHunan Sailong Pharmaceutical Co.,Ltd国药准字H201933632022/04/07Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Tranexamic Acid InjectionHunan Sailong Pharmaceutical Co.,LtdHunan Sailong Pharmaceutical Co.,Ltd国药准字H201835072022/03/02Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Tranexamic Acid InjectionHunan Sailong Pharmaceutical Co.,LtdHunan Sailong Pharmaceutical Co.,Ltd国药准字H202270242022/03/02Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Parecoxib Sodium for InjectionHunan Sailong Pharmaceutical Co.,LtdHunan Sailong Pharmaceutical Co.,Ltd国药准字H202270012022/01/05Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Parecoxib Sodium for InjectionHunan Sailong Pharmaceutical Co.,LtdHunan Sailong Pharmaceutical Co.,Ltd国药准字H201932172022/01/05Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Milrinone InjectionHunan Sailong Pharmaceutical Co.,LtdHunan Sailong Pharmaceutical Co.,Ltd国药准字H202171392021/12/24Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Milrinone InjectionHunan Sailong Pharmaceutical Co.,LtdHunan Sailong Pharmaceutical Co.,Ltd国药准字H201431222021/12/24Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Pantoprazole Sodium For InjectionHunan Sailong Pharmaceutical Co.,LtdHunan Sailong Pharmaceutical Co.,Ltd国药准字H201233692021/08/25Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Omeprazole Sodium for InjectionHunan Sailong Pharmaceutical Co.,LtdHunan Sailong Pharmaceutical Co.,Ltd国药准字H201733152021/05/14Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Esomeprazole Sodium for InjectionHunan Sailong Pharmaceutical Co.,LtdHunan Sailong Pharmaceutical Co.,Ltd国药准字H202037202020/12/25Generic approved under the new chemical-drug registration classificationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

32 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.

NameCompany / applicantRegistration numberStatusSource update dateView source
克林霉素磷酸酯 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdY20250000203I2025/03/14CDE ↗
培美曲塞二钠 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdY20240001111A2026/05/28CDE ↗
硫酸艾沙康唑 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdY20240001110I2024/11/06CDE ↗
磷酸特地唑胺 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdY20240000924A2026/04/23CDE ↗
右兰索拉唑 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdY20240000786A2025/12/11CDE ↗
门冬氨酸镁 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdY20240000685A2025/11/26CDE ↗
门冬氨酸钾 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdY20240000684A2025/11/26CDE ↗
吡拉西坦 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdY20230000964A2025/01/21CDE ↗
尼可地尔 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdY20230000829A2024/12/11CDE ↗
伏立康唑 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdY20230000848A2025/02/19CDE ↗
法莫替丁 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdY20230000305A2024/12/31CDE ↗
奥美拉唑钠 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdY20230000255A2024/09/02CDE ↗
氟尿嘧啶 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdY20230000190A2024/09/30CDE ↗
托拉塞米 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdY20230000254A2024/09/02CDE ↗
盐酸艾司洛尔 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdY20230000197A2026/03/11CDE ↗
富马酸丙酚替诺福韦 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdY20220000689A2024/05/31CDE ↗
阿哌沙班 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdY20210001070A2023/12/13CDE ↗
利伐沙班 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdY20210001030A2023/05/30CDE ↗
普瑞巴林 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdY20210000955A2024/03/07CDE ↗
福沙匹坦双葡甲胺 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdY20210000425A2024/06/28CDE ↗
氨甲环酸 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdY20210000177A2026/05/08CDE ↗
赖氨匹林 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdY20190021313A2024/05/21CDE ↗
左旋泮托拉唑钠 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdY20190000894I2019/11/20CDE ↗
米力农 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdY20190007466A—CDE ↗
单唾液酸四己糖神经节苷脂钠 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdY20190006297A—CDE ↗
多立培南 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdY20170001690I—CDE ↗
右旋兰索拉唑 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdY20170001520I—CDE ↗
阿加曲班 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdY20170001241A2023/12/05CDE ↗
门冬氨酸鸟氨酸 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdY20170000711A2023/07/04CDE ↗
帕瑞昔布钠 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdY20170000607A2023/08/24CDE ↗
艾司奥美拉唑钠 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdY20170000550A2025/05/07CDE ↗
替加环素 · No verified English nameHunan Sailong Pharmaceutical Co.,LtdY20170000076A2024/06/25CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

10 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Isavuconazonium Sulfate for Injection CYHS2500335Generic2025/01/17Hunan Sai Long Pharma (Changsha) Co., Ltd. romanized; Hunan Sailong Pharmaceutical Co.,LtdCDE ↗
Nicorandil for Injection CYHS2401411Generic2024/05/11Hunan Sai Long Pharma (Changsha) Co., Ltd. romanized; Hunan Sailong Pharmaceutical Co.,LtdCDE ↗
Nicorandil for Injection CYHS2401410Generic2024/05/11Hunan Sai Long Pharma (Changsha) Co., Ltd. romanized; Hunan Sailong Pharmaceutical Co.,LtdCDE ↗
Nicorandil for Injection CYHS2401409Generic2024/05/11Hunan Sai Long Pharma (Changsha) Co., Ltd. romanized; Hunan Sailong Pharmaceutical Co.,LtdCDE ↗
Voriconazole for Injection CYHS2303481Generic2023/12/15Hunan Sai Long Pharma (Changsha) Co., Ltd. romanized; Hunan Sailong Pharmaceutical Co.,LtdCDE ↗
Torsemide Injection CYHS2303262Generic2023/11/25Hunan Sai Long Pharma (Changsha) Co., Ltd. romanized; Hunan Sailong Pharmaceutical Co.,LtdCDE ↗
Torsemide Injection CYHS2303261Generic2023/11/25Hunan Sai Long Pharma (Changsha) Co., Ltd. romanized; Hunan Sailong Pharmaceutical Co.,LtdCDE ↗
Famotidine Injection CYHS2303140Generic2023/11/15Hunan Sai Long Pharma (Changsha) Co., Ltd. romanized; Hunan Sailong Pharmaceutical Co.,LtdCDE ↗
Famotidine Injection CYHS2303139Generic2023/11/15Hunan Sai Long Pharma (Changsha) Co., Ltd. romanized; Hunan Sailong Pharmaceutical Co.,LtdCDE ↗
Esmolol Hydrochloride Injection CYHS2301503Generic2023/06/02Hunan Sai Long Pharma (Changsha) Co., Ltd. romanized; Hunan Sailong Pharmaceutical Co.,LtdCDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/18 · Current coverage may be incomplete
Chemical-drug catalogue
Last successful update: 2026/11/18
API registrations
Last successful update: 2026/11/18
NMPA drug delivery notices
Last successful update: 2026/11/19

Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.